PNC Financial Services Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67K Buy
6,259
+990
+19% +$11.1K ﹤0.01% 3208
2026
Q2
$57.8K Buy
5,269
+445
+9% +$4.2K ﹤0.01% 3262
2026
Q1
$39.2K Sell
4,824
-1,077
-18% -$9.25K ﹤0.01% 3357
2025
Q4
$61.3K Sell
5,901
-831
-12% -$8.72K ﹤0.01% 3090
2025
Q3
$59.6K Buy
6,732
+3,769
+127% +$26.9K ﹤0.01% 3107
2025
Q2
$17.1K Buy
2,963
+1,137
+62% +$6.97K ﹤0.01% 3641
2025
Q1
$12.1K Buy
1,826
+548
+43% +$4.27K ﹤0.01% 3756
2024
Q4
$11.1K Buy
1,278
+1,257
+5,986% +$18.1K ﹤0.01% 3758
2024
Q3
$410 Buy
21
+3
+17% +$61 ﹤0.01% 4589
2024
Q2
$371 Buy
18
+12
+200% +$247 ﹤0.01% 4575
2024
Q1
$128 Hold
6
– – ﹤0.01% 4640
2023
Q4
$86 Buy
+6
New +$59 ﹤0.01% 4526
2023
Q3
– Sell
-341
Closed -$3.61K – 4685
2023
Q2
$3.61K Buy
341
+181
+113% +$2.14K ﹤0.01% 4199
2023
Q1
$1.96K Hold
160
– – ﹤0.01% 4318
2022
Q4
$1.99K Hold
160
– – ﹤0.01% 4259
2022
Q3
$2K Buy
+160
New +$2.47K ﹤0.01% 4185
2022
Q2
– Sell
-27
Closed – – 4618
2022
Q1
$0 Buy
+27
New +$390 ﹤0.01% 4623
2021
Q4
– Sell
-161
Closed -$3K – 4536
2021
Q3
$3K Buy
161
+128
+388% +$2.41K ﹤0.01% 4042
2021
Q2
$1K Sell
33
-22
-40% -$546 ﹤0.01% 4126
2021
Q1
$2K Sell
55
-41
-43% -$1.3K ﹤0.01% 3958
2020
Q4
$3K Buy
+96
New +$3.37K ﹤0.01% 3795

Other funds holding KURA

PNC Financial Services Group's KURA Position: Q3 2026 in Review

PNC Financial Services Group increased its Kura Oncology (KURA) stake by 19% in Q3 2026, buying an estimated $11.1K and bringing the position to 6,259 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

PNC Financial Services Group first reported a position in KURA in Q4 2020 and has held it in 21 quarters since. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • PNC Financial Services Group held 6,259 shares of Kura Oncology worth $67K as of Q3 2026.
  • PNC Financial Services Group bought 990 Kura Oncology shares in Q3 2026, an estimated $11.1K.
  • Kura Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3208 holding.
  • PNC Financial Services Group first reported a position in Kura Oncology in Q4 2020 and has held it in 21 quarters since.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.